Purpose of Review: Neurologists are frequently asked to consult on patients with incidentally observed anomalies on brain MRI that may be suggestive of multiple sclerosis (MS). The identification of such findings has important clinical management implications. This review provides an overview and practical clinical approach options for clinicians. Recent Findings: An increase in the number of brain MRI studies performed annually is expected to result in detection of a corresponding greater number of unanticipated anomalies. A disproportionate number of patients referred to neurologists for this reason have punctate subcortical T2 hyperintensities that appear nonspecific in origin rather than having imaging features concerning for MS. However, in some instances, the MRI characteristics appear to be typical for demyelination. When these features are observed, efforts should be pursued to identify an accurate explanation for the preclinical findings through rigorous clinical evaluation, paraclinical testing, and utilization of longitudinal imaging. Summary: The identification of subjects with incidental T2 hyperintensities highly suggestive of MS is important for patient counseling and management. Continued neurologic evaluations and reassessment of the original clinical impression are recommended to ensure accurate interpretation of the available data. 
INTRODUCTION
MRI is invaluable in the field of multiple sclerosis (MS), not only enabling neurologists to diagnose patients following a seminal neurologic event related to central nervous system (CNS) demyelination, but also providing a method of surveillance imaging for the early detection of disease behavior in the presence or absence of diseasemodifying therapy. Conventional MRI sequences allow for the visualization of both remote and more recent white matter inflammatory activity as demonstrated by T1-weighted, T2-weighted, and gadolinium-enhancing lesions, features that appear to be meaningful correlates to assessment of relapse rate. 1 The incorporation of MRI-based data into the diagnostic criteria for MS highlights the importance of observation of structural changes within the CNS. 2 The highly sensitive nature of MRI allows for the easy identification of abnormal or atypical T2 hyperintensities; however, the etiology of such findings may be unclear. A systematic and mindful approach for the initial use of structural neuroimaging studies during a diagnostic workup for a particular clinical scenario may yield findings that are anticipated for that scenario, but may also show unanticipated anomalies that represent features consistent with another, unrelated, disease process. The unanticipated anomalies may be due to disruptions in tissue, bone, or blood vessels, or may be the result of a congenital disorder. In addition, the discovery of abnormal signal intensities, whether consistent with nonspecific white matter changes or highly typical for demyelination, are an expected consequence due to several factors, including the increasing volume of imaging studies being performed annually and improved access to imaging.
Neurologists are routinely faced with consultations on patients with an ''abnormal brain MRI'' study after the formal radiologic interpretation describes the presence of incidental T2 hyperintensities that may be consistent with a broad differential that usually includes ''demyelinating disease.'' The available data from conventional MRI sequences may provide guidance as to the underlying biology of the imaging finding based on the signal characteristics and spatial distribution of the anomalies even when the neurologic examination is normal and, most important, when the patient's clinical history lacks symptoms suggestive of previous neurologic events. Challenges that may arise following the identification of imaging abnormalities include ensuring that the observed features are highly consistent with a disease process, the accurate classification of patients based on existing criteria, the proper counseling of patients, and the recommended medical management. This article focuses on the approach to the patient with incidental brain lesions that may be suggestive of MS.
INITIAL CLINICAL EVALUATION
The identification of unanticipated brain anomalies with varying etiologies may occur following a brain MRI study that is performed for a reason other than for the evaluation of MS. Patients are frequently referred to neurologists following the observation of abnormal findings on a brain imaging study when unanticipated and described by the interpreting neuroradiologist as being potentially concerning for demyelinating disease. Patients and their family members may experience psychological stress after they review the formal description of findings on the report, use online resources to decode the described contents, and are advised of a referral to a neurologist for further consultation. In addition, the recommendation for additional medical visits and reflex diagnostic testing results in an increase in health care costs to the patient along with potential missed days from work.
From a neurologist's perspective, a disproportionate number of patients referred are identified with nonspecific hyperintense punctate lesions that represent sequelae from migraine phenomena, hypertension, or agerelated changes rather than features concerning for MS. The general expectation, even prior to seeing the patient or reviewing the MRI data, is that the visit will be simple and that the described radiologic findings will be of no immediate clinical significance. However, at times the findings may possess characteristics that are typical of MS lesions despite a lack of historical events suggestive of neurologic dysfunction. The discovery of such imaging features creates intersecting social, neuroethical, medicolegal, and proper management challenges. tell us the origin of such findings. Commonly, patients with reports of headache are imaged to further explore the source of pain following a change in the character or frequency of events. Based on the existing scientific literature, white matter hyperintensities previously appeared to be more prevalent in women with migraine with a higher attack frequency. 3, 4 In addition, those with migraine and aura also appeared to be at higher risk for pontine involvement and posterior circulation territory lesions. 5 However, in a 2012 population-based study, progression of deep white matter hyperintensities was identified to be greatest in women with migraine without aura. 6 The observed radiologic evolution, which was found to be modest over the 9-year study period, was also not associated with the frequency of headache events, duration, attack type, treatment, or hypertension. 6 Structural anomalies suggestive of small vessel disease may be due to a proinflammatory or procoagulable state. Effect modification resulting from the use of a variety of agents to treat migraine also needs to be considered. Beyond findings that may be described as the result of migraine, the observation of other incidental anomalies exists.
INCIDENTAL ANOMALIES ON BRAIN MRI
In a study involving 1000 asymptomatic volunteers (55% male) ranging in age from 3 to 83 years (mean age 31 years) who underwent brain MRI, normal studies were identified in the majority of cases (82%). 7 Sinusitis, agerelated changes, solitary nonspecific T2 hyperintensities, and the presence of mastoid/petrous fluid were the most common abnormalities. Interestingly, two confirmed primary CNS tumors (low-grade oligodendroglioma and pilocytic astrocytoma) were identified within the group along with possible demyelinating disease in three individuals.
A greater propensity for intracranial abnormalities appears to exist in individuals who are of more advanced age (older than 50 years of age). 8 In younger groups, a 2013 study involving 1400 youths who volunteered for brain MRI research identified pineal cysts (2.4%) and vascular anomalies (2.6%; vessel asymmetry, vascular anomalies, and possible infarct) as being most prominent. 9 
COMPLEXITIES OF MRI FINDINGS IN PATIENTS WITH AN EXISTING DIAGNOSIS OF MULTIPLE SCLEROSIS
Individuals with an existing diagnosis of MS may transfer care to another health care provider for a variety of reasons, including a change in insurance coverage, relocation to another state for work, or retirement of a previous health care provider. Clinicians who assume the care of new patients with MS are then tasked with verifying both the medical and radiologic history, ensuring that the previously assigned diagnosis was accurate. This involves a comprehensive review of the patient's clinical attack history and personal review of image files from previous MRI studies of the CNS. As the annual costs of the available US Food and Drug Administration (FDA)Yapproved disease-modifying therapies are substantial, the offerings more immense compared to prior years, and adverse event profiles associated with the newer agents vary, a great responsibility is placed on clinicians for the proper use of these agents. Therefore, clinicians may be challenged not only with the report of incidental anomalies in patients without demyelinating symptoms, but also with interpreting imaging data from patients with an established diagnosis of MS who have atypical MRI features (Case 2-1).
KEY POINTS
h A propensity for intracranial abnormalities exists in individuals who are of more advanced age (older than 50 years of age).
h Clinicians may be challenged not only with the report of incidental anomalies in patients without demyelinating symptoms, but also with interpreting imaging data from patients with an established diagnosis of multiple sclerosis but whose MRI features are atypical for multiple sclerosis.
Case 2-1
A 33-year-old woman with a history of hypertension and an existing diagnosis of multiple sclerosis (MS) was seen to establish care in a specialty MS center. On review of her clinical history, she reported frequent falls, fatigue, and visual difficulties described as pain involving both eyes beginning 10 years prior. A brain MRI study had been performed by her previous physician, and the formal report described the presence of more than 20 supratentorial T2 hyperintensities. Based on her clinical history and neuroimaging findings, she was diagnosed with MS at that time by her previous physician. Her initial treatment regimen included exposure to high-dose corticosteroids and management with glatiramer acetate for 7 years. Because of a reported increase in the number of lesions observed on repeat brain MRI studies, her previous physician transitioned her to natalizumab (antiYJC virus antibody positive; antiYJC virus antibody index: 3.12 [optical density measurement of antibody level]), and she had been on treatment for 3 years up until the time of the current visit.
Following a review of the patient's clinical history, current neurologic examination findings, paraclinical laboratory and diagnostic test data, and longitudinal MRI studies of the brain and cervical spine ( Figure 2-1) , the impression was that the original diagnosis was inaccurate. 
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MRI EVOLUTION IN PATIENTS WITH MULTIPLE SCLEROSIS
Over time, an increase in the number of T2-weighted lesions on MRI may be seen in patients with MS. It is important to highlight that the observed changes may not be related to in situ demyelination but to concomitant medical conditions (eg, diabetes mellitus, hypertension, migraines) or the use of recreational substances. Currently, scientific data that detail the frequency of such brain changes, the misinterpretation of these findings as being MS related, or their clinical impact (including changes in MS therapies) in large MS cohorts is lacking.
THE APPROACH TO THE PATIENT WITH AN ABNORMAL MRI STUDY
The systematic approach to the patient with an abnormal brain MRI study containing findings either suggestive or nonsuggestive of MS is highly important. Considerations should be given to congenital, inherited, or acquired disorders along with the temporal profile of radiologic behavior on longitudinal assessments. 11 For more information about inherited disorders, refer to the article ''Genetic Leukoencephalopathies in Adults'' by Adeline Vanderver, MD, 12 in this issue of Continuum. Of critical significance is the acquisition of a complete medical history and a comprehensive neurologic examination.
In an ideal situation, the suggested algorithm would be derived through an evidence-based format. However, a deficiency currently exists within the scientific literature pertaining to systematically acquired data from large cohorts. One of the existing challenges is that absence of a specific diagnosis in patients with white matter anomalies has been estimated to be as high as 30% to 40%. 13 As a result, the determination of sensitivities and specificities for MS or other conditions related to distinguishing MRI features from baseline studies is not possible. The following discussion reflects general guidelines of potential value when faced with a patient with an abnormal brain study suggestive of MS (Figure 2-2) .
The International Panel on Diagnosis of Multiple Sclerosis suggested that the McDonald criteria ''should only be applied in those patients who present with a typical clinically isolated syndrome suggestive of MS or symptoms consistent with a CNS inflammatory demyelinating disease,'' as the criteria were validated in such patients. 2 Clinicians and neuroimaging specialists are sensitive to recognizing patterns as pretest and posttest probabilities KEY POINT h It is essential that a comprehensive review of both clinical and radiologic data be performed in patients presenting with an established diagnosis of multiple sclerosis, to verify fulfillment of existing diagnostic criteria.
Comment. The diagnosis of MS is dependent on both clinical and radiologic elements. Although features of her clinical history may have been supportive of clinical dysfunction related to central nervous system demyelination, the observed radiologic features demonstrated nonspecific punctate high signal changes within the subcortical and deep white matter areas. Although previously observed T2 hyperintensities may resolve over time, the patient's history was nonsupportive of prior imaging features consistent with MS (eg, juxtacortical, periventricular, infratentorial, or spinal cord lesions). Beyond the psychological harm related to the diagnosis previously given to her, further complications for this patient involved the medical expenses related to her medical visits, procedures, and treatments and potential side effects related to treatment. 10 It is essential that a comprehensive review of both clinical and radiologic data be performed in patients with an established diagnosis to verify fulfillment of existing diagnostic criteria.
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for further diagnostic studies based on the initial impressions of a given disorder, whether the impressions are based on the presence of distinct symptoms or the observation of anomalies on a brain MRI scan.
In the case of a patient who presents with incidentally identified features highly suggestive of MS (Case 2-2), the exclusion of other neurologic conditions is essential. Initially, concerns should be focused on the general radiologic phenotype. Lesions typically observed in MS are larger than 3 mm 2 , ovoid, well circumscribed, and homogeneous in signal character. 14, 15 Demyelinating lesions are also located in specific regions within the CNS, distributed mainly at periventricular, juxtacortical, infratentorial, and spinal cord regions. 2 Both the size and signal characteristics differ from nonspecific white matter changes, as these tend to be punctate in character, nonovoid, and frequently located within subcortical regions.
The pattern of lesion distribution should also be evaluated. White matter disorders that are genetically based (ie, leukodystrophies) are usually confluent, with symmetric features. 13 These radiologic features differ from the asymmetric pattern common to MS. It is important to highlight that clinicians may be faced with challenges associated with interpretation of the 
Case 2-2
A 25-year-old right-handed woman with a significant history for migraine was evaluated for an ''abnormal scan'' after a brain MRI study was performed for an increased frequency of headache. The patient reported a recent change in her medication regimen, having recently switched to a different oral contraceptive. Her clinical history was unremarkable for any motor or sensory symptoms. She denied any symptoms consistent with prior demyelinating events. Her neurologic examination was normal. MRI of the brain (Figure 2-3) revealed the presence of multifocal T2 hyperintensities throughout the supratentorial region, with the size, morphology, and location of the lesions highly suggestive of multiple sclerosis (MS). In addition, several enhancing lesions were seen. A cervical MRI was ordered and was normal. A complete blood count with differential, comprehensive metabolic panel, vitamin B 12 level, homocysteine, methylmalonic acid, anticardiolipin antibodies, thyroid function studies, antinuclear antibody screen with reflex testing for extractable nuclear antigens, copper and zinc levels, and screen 
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imaging studies from both heritable and acquired disease processes, depending on the stage of disease present. White matter features on brain MRI may be more multifocal in appearance early in the disease course and, with time, evolve to a more confluent pattern. Observation of the trajectory of radiologic evolution through the patient's longitudinal MRI study data may also assist with providing more insights into the disease process present. 16, 17 The majority of patients who are referred for an abnormal MRI initially read as suggestive of demyelination will have an imaging study containing nonspecific T2-weighted hyperintensities. An estimated 5% to 10% of individuals between 20 and 40 years of age were reported to have imaging features in alignment with small vessel ischemic disease. 18 If the neurologist concludes that the brain MRI features are atypical for MS, repeat imaging may be considered along with a medical workup to evaluate for the etiology of the brain lesions. The imaging features may simply be the result of a spectrum of cryptogenic white matter disorders or an abnormality related to, for example, an abnormal heart rhythm or procoagulable state.
In general, as the MRI pattern of disease is not 100% specific in all cases, at times clinicians may be faced with a brain MRI study that is equivocal for the diagnosis of MS. Fulfillment of the current spatial dissemination criteria may be demonstrated 2 ; however, the signal characteristics and lesion distribution may not be entirely convincing of MS to the examiner. In these situations, further diagnostic imaging of a different portion of the CNS may be of great value (Case 2-3 ). An observed focus within the cervical spinal cord parenchyma typical for CNS demyelination would sway the impression to the spectrum of demyelinating disease. Additionally, an assessment of the CSF profile may improve the specificity of the observed lesions if an elevated IgG index, or the presence of more than two unique oligoclonal bands within spinal fluid KEY POINT h Observation of the trajectory of radiologic evolution through longitudinal MRI study data may assist the clinician with providing more insights into the disease process present.
for Lyme disease was normal. CSF testing revealed an elevated IgG index (1.2) and the presence of four unique oligoclonal bands within the CSF that were not observed in the peripheral sample. An increase in the number of T2 hyperintensities (and new enhancing lesions) was seen on a repeat MRI.
The patient was extensively counseled on the diagnostic criteria for radiologically isolated syndrome and MS. The significance of the observed acute changes (ie, contrast-enhancing lesions) and evolution of her imaging studies were discussed. The potential long-term consequences of the observed lesions and the results of her supportive paraclinical laboratory studies were also discussed. During her visits for reevaluation, efforts were made to find a better explanation for her imaging.
Comment. The observation of imaging features consistent with MS creates challenges for clinicians. How do we effectively counsel patients who present with preclinical features supportive of MS but lack a history of symptoms supportive of the diagnosis? Despite the lack of data regarding treatment, should long-term treatment be recommended when convincing radiologic evidence of evolution exists and when no better explanation for the MRI findings can be identified? Intuitively, therapeutic intervention would appear to be rational given the clinical picture. However, to prevent the overuse of approved therapies in MS, who should be treated?
Beyond these important aspects, efforts to better characterize the condition through reassessment of the clinical history along with pursuing further diagnostic testing (eg, optical coherence tomography, MRI studies of the spinal cord, electrophysiologic studies, blood studies) are highly encouraged. The temporal profile of disease behavior through longitudinal brain imaging is also invaluable as time may allow for further insights into conditions other than demyelinating disease.
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Case 2-3
A 50-year-old right-handed woman with no significant past medical history was evaluated for abnormal imaging results after participating as a healthy control subject in an MRI-based research study at a university. Her clinical history was unremarkable for any clinical symptoms or paroxysmal events suggestive of central nervous system (CNS) demyelination. Her neurologic examination was normal. Imaging data from her research scan contained limited sequences, and a formal clinical MRI of the brain was recommended, which showed high signal abnormalities in the cerebral hemispheres that were determined to be equivocal for radiologic features consistent with multiple sclerosis (Figure 2-4) . Further data were pursued, including imaging of the cervical spinal cord and the use of susceptibility-weighted imaging (SWI) sequences on repeat imaging of the brain. Results revealed findings supportive of a demyelinating process. Comprehensive paraclinical laboratory studies, including a CSF profile, and electrophysiologic studies were performed and were unremarkable. A decision was made to continue future surveillance through repeat clinical visits and MRI studies. 
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(not seen in the periphery), is observed. 19 However, it is important to highlight that an abnormal CSF profile, when observed, is not 100% specific for demyelinating disorders and may be related to other inflammatoryor infectious-related processes. Other diagnostic studies that may be of value include the use of optical coherence tomography 20 along with electrophysiologic studies. 21 The observation of a significant proportion of central veins within brain lesions or the identification of abnormal signals on susceptibilityweighted imaging may also be beneficial in increasing the specificity for MS. 22, 23 When faced with the patient with an abnormal MRI suggestive of MS but who has had no symptoms or signs of CNS demyelination, after a comprehensive review of the medical history and completion of a thorough neurologic examination, further imaging of the cervical spinal cord is recommended. If a high number of lesions are observed, thoracic spinal cord imaging follows in an effort to understand the full extent of involvement within the neuraxis. In established MS cases and independent of clinical features, the presence of thoracic spinal lesions appears to be predicated on the degree of cervical spine involvement. 24 In either the presence or absence of spinal cord lesions, rigorous efforts to verify the observed findings with select paraclinical laboratory, electrophysiologic, or visual imaging studies are encouraged.
The term radiologically isolated syndrome (RIS) was first introduced in 2009 25 to define and characterize the group of individuals who are free of symptoms of CNS demyelination, but who have visible features on brain MRI that appear to be consistent with MS and who appear to be at risk for future demyelinating events. The proposed criteria focused not only on spatial dissemination features, but also included clinical parameters to ensure the absence of prior neurologic symptomatology that may be related to MS, along with an emphasis to exclude other conditions that could better account for the observed lesions on imaging. Individuals identified with RIS who were found to have contrastenhancing lesions on their baseline MRI study were at greater risk of dissemination in time on repeat brain imaging based on earlier cohort studies (hazard ratio = 3.4, 95% confidence interval 1.3 to 8.7, P=.01).
26
The observation of spinal cord involvement in this group is relevant in that one or more lesions increased the risk for a first clinical event. The diagnostic predictive value of an asymptomatic demyelinating lesion in a subject with RIS for development of a seminal neurologic event was found to have a sensitivity of 88% (95% confidence interval 68% to 97%), specificity 92% (80% to 98%), and positive predictive value of 84%. 27 Other investigations aimed at improving the characterization of RIS revealed lower brain volumes when Comment. The approach to the individual with radiologic features that may be interpreted as being equivocal for demyelinating disease should focus on obtaining further evidence supporting CNS demyelination or an alternative acquired, genetic, or congenital condition. Attempts to better characterize the radiologic features through the use of SWI or other imaging techniques and determining if involvement is present in other regions, such as the spinal cord, may assist with refining the overall impression. Even in the setting of evidence supportive of CNS demyelination, continued exploration for a better explanation for the findings is recommended.
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compared to healthy controls and higher lesion magnetization transfer ratios when compared to MS, in addition to the presence of cortical lesions. 28, 29 RADIOLOGICALLY ISOLATED SYNDROME As noted previously, the identification of incidentally identified structural anomalies highly suggestive of MS in asymptomatic individuals is well established. 26, 30, 31 Improvements in scanner hardware (ie, implementation of scanners with higher magnetic field strengths) and advancements in supporting coils and software have improved diagnostic capabilities and our understanding of the disease. These aspects, along with an increase in the number of MRI studies performed annually, contribute to the identification of unanticipated findings. The previously unrecognized CNS lesions seen in RIS are uncovered when a brain MRI is performed for a reason other than for the exploration of symptoms attributable to CNS demyelination. These include evaluations for headaches, ictal events, and trauma as well as studies performed on healthy control subjects involved in medical research and those with a family history of MS who are asymptomatic and interested in assessing if lesions are present. 32 It is important to emphasize, even in the setting of reviewing a brain MRI study containing features highly remarkable for MS, that a comprehensive clinical history and medical evaluation should be performed to exclude the presence of a disease process that could provide a better explanation for the findings demonstrated on MRI. In addition, continued clinical exploration is highly recommended even after RIS is suspected, including reworking the clinical scenario, reevaluating the available data, and taking an adaptive approach if additional diagnostic studies are needed to provide further disease clarification. Figure 2 -2 provides a general guide to the approach to an abnormal MRI study suggestive of MS.
EVIDENCE OF DISEASE PRIOR TO FIRST SYMPTOM ONSET
The notion of presymptomatic disease in the field of MS is clinically supported by the observation of coexisting gadolinium-and nonYgadoliniumenhancing lesions on MRI following a first neurologic event, the observation of significant reductions in global brain volume that appear to be beyond what would be expected for the patient's chronological age, and regional brain volume changes (ie, focal thinning of the corpus callosum). Furthermore, it is plausible that structural abnormalities related to immunerelated injury to the CNS would exist even prior to a first neurologic event, given the varying degrees of injury within lesions and the lack of clinical correlation with MRI findings. 24, 33 Within the scientific literature, well before descriptions from larger clinical cohorts with features supportive of the first visible manifestation of MS, the observation of postmortem incidental demyelinating disease had been well described. 34Y36 In addition, dynamic approaches to evaluating asymptomatic relatives of sporadic and familial MS cases revealed lesion distribution patterns indistinguishable from MS. 37 
RISK FACTORS FOR DEVELOPMENT OF A FIRST NEUROLOGIC EVENT
Following the accurate classification of subjects after a thorough clinical and radiologic evaluation, an important next step is to understand which individuals may be at risk for a first neurologic attack involving sensory, motor, or special sensory function. A 2014 multinational effort involving the retrospective evaluation of 451 patients with RIS, representing data from 22 clinical databases from five countries, aimed to evaluate the time to a first clinical event from an acute attack or the first symptom suggestive of a progressive course. 32 The study cohort principally comprised young white women (78.5%; median age: 37.1 years [range 11 to 74 years]). The top three reasons for the initial scan that showed incidental imaging features suggestive of CNS demyelination included: (1) an evaluation for headache, (2) a traumatic event, and (3) an evaluation for anxiety. Within a 5-year period, 34% of individuals with RIS experienced a seminal neurologic event related to demyelination. The risk factors that appeared to be most relevant included sex, with males having a higher risk; a younger age (younger than 37 years) at RIS diagnosis; and the presence of lesions within the cervical or thoracic spinal cord. An increase in risk for first symptom onset was also clearly related to the number of risk factors present for an individual. This large multinational effort not only supported the existence of RIS but also better defined those at risk for a first neurologic event.
COUNSELING PATIENTS WITH RADIOLOGICALLY ISOLATED SYNDROME When counseling a patient with RIS, the images should be reviewed and the potential origin of the findings on MRI should be discussed. The value of future CNS imaging studies to evaluate for interval changes and education with regard to symptoms commonly experienced by patients with MS should be reviewed. A positive and supportive approach is recommended, stressing the early recognition of the imaging findings and the opportunity to closely monitor for signs of clinical and radiologic change.
Patients should also be advised that continued efforts to identify a better reason for the observed MRI findings will be pursued. As the science related to RIS is still evolving and no clear consensus exists regarding treatment approaches, assurances should also be provided to the patient that studies are ongoing regarding improved diagnostic techniques for the accurate recognition of CNS demyelinating lesions and the impact of early treatment.
CONCLUSION
Health care providers are challenged with formulating an accurate impression and plan following the review of clinical, paraclinical laboratory, and radiologic data in a patient who presents with an abnormal brain MRI. Proper interpretation of the available data is important for medical surveillance recommendations and for preventing the overdiagnosis of asymptomatic demyelinating disease. These efforts help to reduce psychological harm and prevent unnecessary exposure to MS treatments and their associated risks and high costs.
Valid concerns regarding the potential misclassification of anomalies suggestive of MS exist given how commonly nonspecific white matter changes are observed. The use of objective parameters of disease is important, along with an adaptive approach for further diagnostic studies depending on the results obtained from earlier testing or clinical follow-up.
It is not impossible to conceive that a single clinical test, be it a novel imaging technique or biological sample assessment and one with a much higher degree of specificity than any currently available metric, may be all that will be needed for the diagnosis of MS in the future. For now, we are left with utilizing and enhancing the currently available technology and optimizing our interpretation of the acquired data based on existing guidelines.
With projected increases in the utilization of MRI, a greater propensity exists for the identification of unanticipated anomalies that may or may not be consistent with demyelination. Regardless of the white matter characteristics identified, efforts should be pursued to identify an accurate explanation for the preclinical findings. If other supporting paraclinical studies are unremarkable, continued clinical evaluations and the temporal profile of radiologic behavior may also provide insights into the ultimate underlying etiology.
